JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 3, 2006; DOI: 10.1124/jpet.105.098269


0022-3565/06/3172-724-731$20.00
JPET 317:724-731, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.105.098269v1
317/2/724    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Callebert, J.
Right arrow Articles by Maroteaux, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Callebert, J.
Right arrow Articles by Maroteaux, L.

CARDIOVASCULAR

Evidence for a Control of Plasma Serotonin Levels by 5-Hydroxytryptamine2B Receptors in MiceFormula

J. Callebert, J. M. Esteve, P. Hervé, K. Peoc'h, C. Tournois1, L. Drouet, J. M. Launay, and L. Maroteaux

Services de Biochimie et d'Hématologie Biologique, Hôpital Lariboisière, Assistance Publique-Hopitaux de Paris, Paris, France (J.C., K.P., C.T., L.D., J.M.L.); Institut Federatif de Recherche 139, Paris, France (J.C., K.P., C.T., L.D., J.M.L.); Institut de Génétique et Biologie Moléculaire et Cellulaire, Illkirch, France (J.M.E., L.M.); Institut National de la Santé et de la Recherche Médicale U536, Illkirch, France (J.M.E., L.M.); Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7104, Illkirch, France (J.M.E., L.M.); University of Strasbourg, Illkirch, France (J.M.E., L.M.); Laboratoire de Chirurgie Expérimentale Unité Propre de Recherche et de l'Enseignement Supérieur, Equipe d'Accueil, Paris South University, Hôpital Marie Lannelongue, Le Plessis-Robinson, France (P.H.); Institut National de la Santé et de la Recherche Médicale U616, Paris, France (L.M.); Hopital Pitié-Salpetrière, Paris, France (L.M.); and University Pierre et Marie Curie, Paris, France (L.M.)

A correlation between high plasma serotonin levels and total pulmonary resistance was reported in more than 80% of pulmonary hypertensive patients. When submitted to chronic hypoxia (10% O2 for more than 3 weeks), wild-type mice develop lung vascular remodeling and pulmonary hypertension. We previously reported that, in contrast, the development of these hypoxia-dependent alterations is totally abolished in mice with permanent (genetic) or transient (pharmacologic) inactivation of the serotonin 5-hydroxytryptamine (5-HT)2B receptor. In the present study, we asked whether 5-HT2B receptors could be involved in the control of plasma serotonin levels. Further investigating the chronic hypoxic mouse model of pulmonary hypertension, we first show that in wild-type mice, plasma serotonin levels and 5-HT2B receptors expression were significantly increased after chronic exposure to hypoxia. This increase appeared before significant changes in remodeling factors could be detected and persisted when the pathology was established. Conversely, in mice with either genetically or pharmacologically inactive 5-HT2B receptors, plasma serotonin levels were not modified by chronic hypoxia. We then confirmed that 5-HT2B receptors can control plasma serotonin levels by providing in vivo evidence that an acute agonist stimulation of 5-HT2B receptor triggers a transient increase in plasma serotonin that is serotonin transporter dependent and blocked by 5-HT2B receptor-selective antagonist or genetic ablation. Our data support the notion that a 5-HT2B receptor-dependent regulation of serotonin uptake is implicated in the control of plasma serotonin levels.


Received for publication November 7, 2005
Accepted February 2, 2006.

Address correspondence to: Dr. Luc Maroteaux, Institut National de la Santé et de la Recherche Médicale, U616, Hopital Pitié-Salpetrière, Université Pierre et Marie Curie Paris, Bat Pédiatrie, 47 Boulevard de l'Hopital, 75013 Paris, France. E-mail: luc.maroteaux{at}chups.jussieu.fr




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
N. W. Morrell, S. Adnot, S. L. Archer, J. Dupuis, P. Lloyd Jones, M. R. MacLean, I. F. McMurtry, K. R. Stenmark, P. A. Thistlethwaite, N. Weissmann, et al.
Cellular and molecular basis of pulmonary arterial hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S20 - S31.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Fligny, Y. Fromes, P. Bonnin, M. Darmon, E. Bayard, J.-M. Launay, F. Cote, J. Mallet, and G. Vodjdani
Maternal serotonin influences cardiac function in adult offspring
FASEB J, July 1, 2008; 22(7): 2340 - 2349.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Doly, E. Valjent, V. Setola, J. Callebert, D. Herve, J.-M. Launay, and L. Maroteaux
Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro
J. Neurosci., March 12, 2008; 28(11): 2933 - 2940.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Collet, C. Schiltz, V. Geoffroy, L. Maroteaux, J.-M. Launay, and M.-C. de Vernejoul
The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation
FASEB J, February 1, 2008; 22(2): 418 - 427.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Papageorgiou and C. Denef
Stimulation of Growth Hormone Release by 5-Hydroxytryptamine (5-HT) in Cultured Rat Anterior Pituitary Cell Aggregates: Evidence for Mediation by 5-HT2B, 5-HT7, 5-HT1B, and Ketanserin-Sensitive Receptors
Endocrinology, September 1, 2007; 148(9): 4509 - 4522.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Li, Y. Liu, P. Dutt, B. L. Fanburg, and D. Toksoz
Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L463 - L471.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Papageorgiou and C. Denef
Estradiol Induces Expression of 5-Hydroxytryptamine (5-HT) 4, 5-HT5, and 5-HT6 Receptor Messenger Ribonucleic Acid in Rat Anterior Pituitary Cell Aggregates and Allows Prolactin Release via the 5-HT4 Receptor
Endocrinology, March 1, 2007; 148(3): 1384 - 1395.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Morecroft, Y. Dempsie, M. Bader, D. J. Walther, K. Kotnik, L. Loughlin, M. Nilsen, and M. R. MacLean
Effect of Tryptophan Hydroxylase 1 Deficiency on the Development of Hypoxia-Induced Pulmonary Hypertension
Hypertension, January 1, 2007; 49(1): 232 - 236.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Ni, K. Lookingland, and S. W. Watts
Arterial 5-Hydroxytryptamine Transporter Function Is Impaired in Deoxycorticosterone Acetate and N{omega}-Nitro-L-Arginine But Not Spontaneously Hypertensive Rats
Hypertension, July 1, 2006; 48(1): 134 - 140.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.